Perjeta 420 mg, Konzentrat zur Herstellung einer Infusionslösung
7680625100014
CH-62510
Konzentrat
Associated product:
PERJETA conc perf 420 mg/14 ml flac 14 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
pertuzumabum
|
420.0 MG | Substance | Wirkstoff (Principe actif) |
|
histidinum
|
- | Substance | HNIDK |
|
acidum aceticum glaciale
|
- | Substance | HNIDK |
|
saccharum
|
- | Substance | HNIDK |
|
polysorbatum 20
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 2530.95
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/07/2015
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 62510
- Drug name
- Perjeta, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOPA
- ATC Code
- L01FD02
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 13/08/2012
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- PERJETA conc perf 420 mg/14 ml flac 14 ml
- Description (DE)
- PERJETA Inf Konz 420 mg/14 ml Durchstf 14 ml
- Market launch
- 13/08/2012
- Narcotic (BTM)
- No